5280 Pep

Never sore. Not tired. Healed up.

What if the problem isn’t your age… but your mitochondria?

Most people have never heard of mitochondria until high school biology.

Then they forget about them.

But here’s the interesting part…

Every cell in your body depends on tiny structures called mitochondria to produce the energy that keeps you alive.

They’re often called the powerhouses of the cell, but they do much more than just make energy.

Researchers are studying how mitochondrial health may influence:

⚡ Cellular energy production

🧠 Cognitive function

❤️ Cardiovascular health

💪 Recovery and resilience

🔥 Oxidative stress

As we age, our mitochondria can become less efficient. That’s one reason scientists have become increasingly interested in compounds that specifically target mitochondrial function instead of simply masking fatigue with more caffeine or stimulants.

One of the most intriguing compounds in this area is SS-31 (Elamipretide).

Unlike many compounds that work through hormones or appetite pathways, SS-31 is being studied because it interacts directly with the inner mitochondrial membrane, where our cells generate ATP—the energy currency that powers nearly everything we do.

Human research is still emerging, but it’s one of the more fascinating areas of mitochondrial science right now.

That’s exactly why it earned the next spot in the Venatic Research Series.

👇 I’d love to hear your thoughts…

Before today, had you ever heard of SS-31 or mitochondrial peptides?

If there’s another peptide or research topic you’d like me to break down in a future post, leave it in the comments.

Next week, July 23-24, the FDA's Pharmacy Compounding Advisory Committee will review seven peptides being considered for inclusion on the 503A Bulks List: BPC-157, KPV, TB-500, MOTS-c, DSIP, Semax, and Epitalon.

Why does this matter?
If these peptides are ultimately added to the list, it could help preserve or expand future patient access to clinician-guided peptide care through eligible compounding pharmacies. While the committee's recommendations are not final FDA decisions, they are an important step in the FDA's review process.

If you care about the future of personalized medicine and peptide therapy, this is a meeting worth paying attention to.

We'll be following the discussions and sharing updates as they become available.

I know 60+ year old men that have completely stopped drinking energy drinks and coffee. Ask me about NAD+.

Offer Expires 7.4.26
Www.5280peptides.com